LATAM Surgical Staplers Market

The LATAM surgical staplers market is projected to reach USD 0.36 billion by 2031 from USD 0.25 billion in 2026, at a CAGR of 7.4%.

Surgical procedures across the LATAM countries are expected to grow steadily due to improved healthcare access, disease diagnosis, and population growth. Brazil and Mexico together account for a significant portion of the total number of surgeries performed in the broad categories of general, gastrointestinal, gynecological, and trauma surgeries, all of which involve the use of staplers. With the expansion of surgical services beyond the capital into second-tier towns, caseloads are sure to increase. Staplers are gaining popularity as they help standardize surgical outcomes and improve operating room efficiency. This is driving steady demand across linear, circular, and skin stapler segments.

This report segments the surgical staplers market by type, technology, usability, application, and end user.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in this market include Medtronic Plc (Ireland), Johnson & Johnson (Ethicon, Inc.) (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), Intuitive Surgical Inc (US), 3M Company (US), CONMED Corporation (US), B. Braun SE (Germany), Smith+Nephew (UK), Welfare Medical Ltd. (UK), Reach Surgical (China), Meril Life Sciences Pvt Ltd. (India), XNY Medical (China), Purple Surgical (UK), Frankenman International Ltd. (China), Lexington Medical (US), Ningbo Verykind Medical Device Co., Ltd (China), Waston Medical Corporation (China), Suture Planet (India), Dolphin Suture (India), Touchstone International Medical Science Co. Ltd. (China), NewGen Surgical (US), Edges Medicare Private Limited (India), Golden Stapler Surgical Co., Ltd., (China), Victor Medical Instruments Co., Ltd. (China), and Volkmann Medizintechnik GmbH (Germany).

Medtronic Plc (Ireland)

It operates in high-turbulence markets driven by fast-paced technological advances, which require continued product development, improvements, and innovation to sustain its leadership in the market. R&D efforts at Medtronic Plc are aligned to achieve technological superiority, ensuring that patients receive the most up-to-date and effective forms of treatment. It encompasses strategies for enhancing and expanding product utilization, developing new therapies, and facilitating third-party collaboration in co-funding technological advancements based on innovation, productivity, and clinical needs, to support improvements in patient care and establish a new standard of care. In May 2024, Covidien Japan, Inc., a Medtronic subsidiary, entered into a service agreement with HOGY Medical Co., Ltd. to jointly market SureFinD, a marking device for lung cancer patients. When used alongside Medtronic Covidien’s Endo GIA surgical stapler, the solution is designed to support a more integrated approach to lesion resection.

Johnson & Johnson (Ethicon, Inc.) (US)

Ethicon leverages the global infrastructure of Johnson & Johnson to sell its products while benefiting from the symbiotic advantages of shared resources in R&D, technological expertise, strategic initiatives, and project execution. Such critical R&D activities are carried out through innovation centers in Somerville and  Cincinnati, US; Norderstedt, Germany; and Suzhou, China. Ethicon closely collaborates with surgeons on new product development; in particular, it launched the ECHELON LINEAR Cutter with 3D-Stapling & Gripping Surface Technology (GST) in May 2023, offering improved staple line security. Ethicon boasts strong representations in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with high investments in R&D and sales, especially in emerging economies.

Lepu Medical Technology (Beijing) CO., LTD. (China)

Lepu Medical Technology emphasizes cost-effective innovation in its products. It designs advanced yet low-cost solutions, customized for growing markets where cost can be a critical factor. The company has also invested heavily in research and development to create safe and user-friendly products that meet both international standards and local requirements. In 2023, Lepu Medical Technology invested USD 124 million in R&D. The company has developed a vast distribution network across Asia and has expanded into international markets through partnerships and collaborations, thereby strengthening its global presence. 

Market Ranking

The LATAM surgical staplers market is highly consolidated, with prominent players accounting for over 80% of the total market share in 2025. Some key players dominating the market are Medtronic Plc (Ireland), Johnson & Johnson (Ethicon, Inc.) (US), Lepu Medical Technology (Beijing) Co., Ltd. (China), B. Braun SE (Germany), and 3M Company (US).

The LATAM surgical staplers market is characterized by the presence of multinational players supported by an increasing number of regional distributors and local manufacturers. In recent years, companies have expanded portfolios of cost-efficient staplers to meet the needs of price-sensitive clients. Rising surgical volumes, improved hospital infrastructure, and the wider adoption of minimally invasive procedures are driving manufacturers to strengthen their distribution networks and establish regional partnerships across major Latin American markets.

Related Reports:

LATAM Surgical Staplers Market by Type (Linear, Circular, Skin, Curved), Technology (Manual, Powered), Usability (Disposable, Reusable), Application (Abdominal & Pelvic Surgery, General Surgery, Orthopedic Surgery), End User- Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com